| dc.contributor.author | Ploegh, Hidde | |
| dc.contributor.author | Sun, Jiusong | |
| dc.contributor.author | Hartvigsen, Karsten | |
| dc.contributor.author | Chou, Meng-Yun | |
| dc.contributor.author | Zhang, Yadong | |
| dc.contributor.author | Sukhova, Galina K. | |
| dc.contributor.author | Zhang, Jie | |
| dc.contributor.author | Lopez-Ilasaca, Marco | |
| dc.contributor.author | Diehl, Cody J. | |
| dc.contributor.author | Yakov, Niva | |
| dc.contributor.author | Harats, Dror | |
| dc.contributor.author | George, Jacob | |
| dc.contributor.author | Witztum, Joseph L. | |
| dc.contributor.author | Libby, Peter | |
| dc.contributor.author | Shi, Guo-Ping | |
| dc.date.accessioned | 2012-10-25T20:54:32Z | |
| dc.date.available | 2012-10-25T20:54:32Z | |
| dc.date.issued | 2010-08 | |
| dc.date.submitted | 2009-07 | |
| dc.identifier.issn | 0009-7322 | |
| dc.identifier.issn | 1524-4539 | |
| dc.identifier.uri | http://hdl.handle.net/1721.1/74265 | |
| dc.description | August 25, 2010 | en_US |
| dc.description.abstract | Background: Adaptive immunity and innate immunity play important roles in atherogenesis. Invariant chain (CD74) mediates antigen-presenting cell antigen presentation and T-cell activation. This study tested the hypothesis that CD74-deficient mice have reduced numbers of active T cells and resist atherogenesis.
Methods and Results: In low-density lipoprotein receptor–deficient (Ldlr[superscript −/−]) mice, CD74 deficiency (Ldlr[superscript −/−]Cd74[superscript −/−]) significantly reduced atherosclerosis and CD25+-activated T cells in the atheromata. Although Ldlr[superscript −/−]Cd74[superscript −/−] mice had decreased levels of plasma immunoglobulin (Ig) G1, IgG2b, and IgG2c against malondialdehyde-modified LDL (MDA-LDL), presumably as a result of impaired antigen-presenting cell function, Ldlr[superscript −/−]Cd74[superscript −/−] mice showed higher levels of anti–MDA-LDL IgM and IgG3. After immunization with MDA-LDL, Ldlr[superscript −/−]Cd74[superscript −/−] mice had lower levels of all anti–MDA-LDL Ig isotypes compared with Ldlr[superscript −/−] mice. As anticipated, only Ldlr[superscript −/−] splenocytes responded to in vitro stimulation with MDA-LDL, producing Th1/Th2 cytokines. Heat shock protein-65 immunization enhanced atherogenesis in Ldlr[superscript −/−] mice, but Ldlr[superscript −/−] Cd74[superscript −/−] mice remained protected. Compared with Ldlr[superscript −/−] mice, Ldlr[superscript −/−]Cd74[superscript −/−] mice had higher anti–MDA-LDL autoantibody titers, fewer lesion CD25+-activated T cells, impaired release of Th1/Th2 cytokines from antigen-presenting cells after heat shock protein-65 stimulation, and reduced levels of all plasma anti–heat shock protein-65 Ig isotypes. Cytofluorimetry of splenocytes and peritoneal cavity cells of MDA-LDL– or heat shock protein-65–immunized mice showed increased percentages of autoantibody-producing marginal zone B and B-1 cells in Ldlr[superscript −/−]Cd74[superscript −/−] mice compared with Ldlr[superscript −/−] mice.
Conclusions: Invariant chain deficiency in Ldlr[superscript −/−] mice reduced atherosclerosis. This finding was associated with an impaired adaptive immune response to disease-specific antigens. Concomitantly, an unexpected increase in the number of innate-like peripheral B-1 cell populations occurred, resulting in increased IgM/IgG3 titers to the oxidation-specific epitopes. | en_US |
| dc.language.iso | en_US | |
| dc.publisher | Ovid Technologies (Wolters Kluwer) -American Heart Association | en_US |
| dc.relation.isversionof | http://dx.doi.org/10.1161/circulationaha.109.891887 | en_US |
| dc.rights | Creative Commons Attribution-Noncommercial-Share Alike 3.0 | en_US |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/ | en_US |
| dc.source | PMC | en_US |
| dc.title | Deficiency of Antigen Presenting Cell Invariant Chain Reduces Atherosclerosis in Mice | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Sun, J. et al. “Deficiency of Antigen-Presenting Cell Invariant Chain Reduces Atherosclerosis in Mice.” Circulation 122.8 (2010): 808–820. | en_US |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | en_US |
| dc.contributor.department | Whitehead Institute for Biomedical Research | en_US |
| dc.contributor.mitauthor | Ploegh, Hidde | |
| dc.relation.journal | Circulation | en_US |
| dc.eprint.version | Author's final manuscript | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dspace.orderedauthors | Sun, J.; Hartvigsen, K.; Chou, M.-Y.; Zhang, Y.; Sukhova, G. K.; Zhang, J.; Lopez-Ilasaca, M.; Diehl, C. J.; Yakov, N.; Harats, D.; George, J.; Witztum, J. L.; Libby, P.; Ploegh, H.; Shi, G.-P. | en |
| dc.identifier.orcid | https://orcid.org/0000-0002-1090-6071 | |
| mit.license | OPEN_ACCESS_POLICY | en_US |
| mit.metadata.status | Complete | |